GenoFocus Statistics

Total Valuation

GenoFocus has a market cap or net worth of KRW 102.68 billion. The enterprise value is 138.93 billion.

Market Cap	102.68B
Enterprise Value	138.93B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

GenoFocus has 24.19 million shares outstanding. The number of shares has increased by 2.20% in one year.

Current Share Class	n/a
Shares Outstanding	24.19M
Shares Change (YoY)	+2.20%
Shares Change (QoQ)	+2.81%
Owned by Insiders (%)	14.23%
Owned by Institutions (%)	2.70%
Float	13.83M

Valuation Ratios

The trailing PE ratio is 93.45.

PE Ratio	93.45
Forward PE	n/a
PS Ratio	2.80
PB Ratio	4.04
P/TBV Ratio	4.37
P/FCF Ratio	77.40
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.11, with an EV/FCF ratio of 104.72.

EV / Earnings	132.98
EV / Sales	3.99
EV / EBITDA	25.11
EV / EBIT	186.34
EV / FCF	104.72

Financial Position

The company has a current ratio of 0.62, with a Debt / Equity ratio of 1.48.

Current Ratio	0.62
Quick Ratio	0.47
Debt / Equity	1.48
Debt / EBITDA	7.77
Debt / FCF	32.43
Interest Coverage	0.17

Financial Efficiency

Return on equity (ROE) is 13.20% and return on invested capital (ROIC) is 0.56%.

Return on Equity (ROE)	13.20%
Return on Assets (ROA)	0.49%
Return on Capital (ROIC)	0.56%
Revenue Per Employee	497.63M
Profits Per Employee	14.92M
Employee Count	70
Asset Turnover	0.37
Inventory Turnover	3.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.08% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+18.08%
50-Day Moving Average	3,945.00
200-Day Moving Average	3,762.43
Relative Strength Index (RSI)	55.56
Average Volume (20 Days)	187,968

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GenoFocus had revenue of KRW 34.83 billion and earned 1.04 billion in profits. Earnings per share was 45.42.

Revenue	34.83B
Gross Profit	13.06B
Operating Income	745.56M
Pretax Income	4.38B
Net Income	1.04B
EBITDA	5.53B
EBIT	745.56M
Earnings Per Share (EPS)	45.42

Full Income Statement

Balance Sheet

The company has 11.05 billion in cash and 43.02 billion in debt, giving a net cash position of -31.97 billion or -1,321.73 per share.

Cash & Cash Equivalents	11.05B
Total Debt	43.02B
Net Cash	-31.97B
Net Cash Per Share	-1,321.73
Equity (Book Value)	29.16B
Book Value Per Share	1,050.57
Working Capital	-14.89B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.81 billion and capital expenditures -478.48 million, giving a free cash flow of 1.33 billion.

Operating Cash Flow	1.81B
Capital Expenditures	-478.48M
Free Cash Flow	1.33B
FCF Per Share	54.85

Full Cash Flow Statement

Margins

Gross margin is 37.48%, with operating and profit margins of 2.14% and 3.00%.

Gross Margin	37.48%
Operating Margin	2.14%
Pretax Margin	12.57%
Profit Margin	3.00%
EBITDA Margin	15.89%
EBIT Margin	2.14%
FCF Margin	3.81%

Dividends & Yields

GenoFocus does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.20%
Shareholder Yield	-2.20%
Earnings Yield	1.07%
FCF Yield	1.29%

Stock Splits

The last stock split was on March 19, 2018. It was a forward split with a ratio of 2.

Last Split Date	Mar 19, 2018
Split Type	Forward
Split Ratio	2

Scores

GenoFocus has an Altman Z-Score of 0.54. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.54
Piotroski F-Score	n/a